Version 2024

2024 ICD-10-CM Diagnosis Code D02

Carcinoma in situ of middle ear and respiratory system

ICD-10-CM Code:
D02
ICD-10 Code for:
Carcinoma in situ of middle ear and respiratory system
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • In situ neoplasms
      (D00-D09)
      • Carcinoma in situ of middle ear and respiratory system
        (D02)

D02 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of carcinoma in situ of middle ear and respiratory system. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Carcinoma in situ of middle ear and respiratory system

Non-specific codes like D02 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for carcinoma in situ of middle ear and respiratory system:

  • Use D02.0 for Carcinoma in situ of larynx - BILLABLE CODE

  • Use D02.1 for Carcinoma in situ of trachea - BILLABLE CODE

  • D02.2 for Carcinoma in situ of bronchus and lung - NON-BILLABLE CODE

  • Use D02.20 for Carcinoma in situ of unspecified bronchus and lung - BILLABLE CODE

  • Use D02.21 for Carcinoma in situ of right bronchus and lung - BILLABLE CODE

  • Use D02.22 for Carcinoma in situ of left bronchus and lung - BILLABLE CODE

  • Use D02.3 for Carcinoma in situ of other parts of respiratory system - BILLABLE CODE

  • Use D02.4 for Carcinoma in situ of respiratory system, unspecified - BILLABLE CODE

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Use Additional Code

Use Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
  • code to identify:
  • exposure to environmental tobacco smoke Z77.22
  • exposure to tobacco smoke in the perinatal period P96.81
  • history of tobacco dependence Z87.891
  • occupational exposure to environmental tobacco smoke Z57.31
  • tobacco dependence F17
  • tobacco use Z72.0

Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • melanoma in situ D03

Patient Education


Cancer

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.